Preterm infant study finds proactive use of Prolact CR cream improves growth and reduces NICU costs
Type: Press Releases
Topic(s): Cost Savings / Cost Effectiveness Early Fortification Growth Product
Prolacta Bioscience demonstrates leadership in human milk science with history of voluntarily reviewing health claims with the FDA
Type: Press Releases
Topic(s): Company
Human milk-based fortifiers cut mortality rate by 50% in preterm infants, independent study shows
Type: Press Releases
Topic(s): Clinical Studies Mortality
Motorcycle enthusiast and mother of 2, Amanda, loves helping premature babies
Type: Donor Stories
Topic(s): Tiny Treasures
Mom and nurse Kayla helps others by donating
Type: Donor Stories
Topic(s): Tiny Treasures
Firefighter and donor mom Rachel becomes CLC certified in her “spare time”
Type: Donor Stories
Topic(s): Tiny Treasures
Nurse, lactation consultant, and mother of 3 Megan finds time to donate
Type: Donor Stories
Topic(s): Tiny Treasures
Study shows exclusive human milk diet benefits term infants post-gastroschisis repair; Data to be presented at ESPGHAN 2024 meeting
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events
Pediatric Academic Societies Meeting includes symposium on cost-effectiveness of implementing exclusive human milk-based nutrition for premature infants
Type: Press Releases
Topic(s): Conferences and Events
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com